InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（9 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
9
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Hecht Beth, 管理人员. Officer active across 3 companies, notably Xeris Biopharma Holdings, Inc.. Cumulatively, 21 filings have been recorded. Breakdown: 0 buy · 9 sells. Total volume traded: €1m. History available since 3 January 2022. The latest transaction was disclosed on 1 September 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Hecht Beth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
16,666 股@ US$8.48640.0060% mcap9.5% 占其流量Common StockSEC:0001652410-26-000018:0
16,666 股@ US$8.01350.0058% mcap10.0% 占其流量Common StockSEC:0001652410-26-000016:0
16,667 股@ US$6.22820.0044% mcap15.2% 占其流量Common StockSEC:0001652410-26-000010:0
16,667 股@ US$5.991412.9% 占其流量Common StockSEC:0001652410-26-000008:0
16,567 股@ US$6.24018.2% 占其流量Common StockSEC:0001652410-26-000006:0
121,293 股0Common StockSEC:0001652410-26-000004:0
16,667 股@ US$7.42649.8% 占其流量Common StockSEC:0001652410-26-000002:0
16,667 股@ US$7.006711.5% 占其流量Common StockSEC:0001652410-25-000005:0
16,667 股@ US$7.397613.7% 占其流量Common StockSEC:0001652410-25-000003:0
40,000 股@ US$5.431140.2% 占其流量Common StockSEC:0001867096-25-000047:0
45,909 股@ US$3.5631.7% 占其流量Common StockSEC:0001867096-25-000025:0
32,039 股@ US$3.6122.7% 占其流量Common StockSEC:0001867096-25-000011:0
14,037 股@ US$2.115.4% 占其流量Common StockSEC:0001867096-24-000170:0
750,000 股0Common StockSEC:0001867096-24-000015:0
15,853 股0Ordinary SharesSEC:0001209191-23-037406:0
350,000 股0Common StockSEC:0001867096-23-000020:0
36,798 股0Ordinary SharesSEC:0001209191-22-039311:0
7,642 股0Ordinary SharesSEC:0001209191-22-020618:0
225,000 股0Common StockSEC:0001867096-22-000009:0
26,366 股Common StockSEC:0000899243-21-039248:0
26,366 股Common StockSEC:0000899243-21-039317:0
21 条申报中的 21 条
About Hecht Beth
Hecht Beth is a dirigente linked to Xeris Biopharma Holdings, Inc., Iterum Therapeutics plc and Xeris Pharmaceuticals INC. She has made 19 filings in total, and in the recent filings available, the modal transaction nature is a sale, with EUR 774339 of sales and EUR 0 of purchases between 2021-10-05 and 2026-05-01.
